These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 527518)

  • 1. [Treatment of uremic symptoms and its metabolic consequences].
    Forsström J
    Duodecim; 1979; 95(22):1526-32. PubMed ID: 527518
    [No Abstract]   [Full Text] [Related]  

  • 2. [Water and salt metabolism in chronic uremigenic nephropathies].
    Mioni G; Cristinelli L; Messa PG; Montanaro D
    G Clin Med; 1980 May; 61(5):332-41. PubMed ID: 7450354
    [No Abstract]   [Full Text] [Related]  

  • 3. [Infusion therapy in kidney diseases].
    Düsing R; Kramer HJ
    Infusionsther Klin Ernahr; 1975 Dec; 2(6):433-7. PubMed ID: 812817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremic syndrome and end-stage renal disease: physical manifestations and beyond.
    Chikotas N; Gunderman A; Oman T
    J Am Acad Nurse Pract; 2006 May; 18(5):195-202. PubMed ID: 16681706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 6. The anglerfish and uremic toxins.
    Lowenstein J
    FASEB J; 2011 Jun; 25(6):1781-5. PubMed ID: 21622695
    [No Abstract]   [Full Text] [Related]  

  • 7. [The visual apparatus in chronic uremic patients during periodic hemodialytic treatment. 3. Changes in the caliber of the retinal vessels during hemodialysis].
    Sorice PS; Esposito E; Tretola L; Tufano L; Ambrosio A
    Rass Int Clin Ter; 1971 Aug; 51(15):948-52. PubMed ID: 5096694
    [No Abstract]   [Full Text] [Related]  

  • 8. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
    Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M
    G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain dysfunction in uremia: a question of cortical hyperexcitability?
    Battaglia F; Quartarone A; Bagnato S; Rizzo V; Morgante F; Floccari F; Romeo A; Sant'Angelo A; Grasso G; Girlanda P; Buemi M
    Clin Neurophysiol; 2005 Jul; 116(7):1507-14. PubMed ID: 15908270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extracellular and intracellular water-electrolyte changes and acid-base equilibrium changes after extracorporeal hemodialysis in chronic uremic patients].
    Acquarone N; Bertocchi I; De Ferrari G; Gurreri G; Menozzi PG; Tizianello A
    Minerva Nefrol; 1970; 17(6):190-7. PubMed ID: 5516054
    [No Abstract]   [Full Text] [Related]  

  • 12. [Amino acid metabolic disorder in kidney failure (a review of the literature)].
    Terekhov NT; Levchenko IV; Lipkan GN
    Vrach Delo; 1982 Nov; (11):12-6. PubMed ID: 6818768
    [No Abstract]   [Full Text] [Related]  

  • 13. An update on uremic toxins.
    Ringoir S
    Kidney Int Suppl; 1997 Nov; 62():S2-4. PubMed ID: 9350668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Uremic polyneuropathy in patients treated by chronic hemodialysis].
    Ostroumova IV
    Sov Med; 1975 Jul; (7):55-60. PubMed ID: 766226
    [No Abstract]   [Full Text] [Related]  

  • 15. Nutrition in renal disease.
    Richards P; Ell S
    Hum Nutr Clin Nutr; 1982; 36(2):103-13. PubMed ID: 7050028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Water-electrolyte and acid-base disorders in terminal chronic renal insufficiency. Their treatment by peritoneal dialysis].
    Exposito C; Baumelou A
    Soins; 1981 Feb; 26(3):37-42. PubMed ID: 6910230
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vitamin K1 and C metabolism in uremia during hemodialysis].
    Bakaev VV; Khomenko VF
    Urol Nefrol (Mosk); 1991; (1):40-3. PubMed ID: 1858205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic anomaly and uremic toxins in chronic renal insufficiency].
    Ueda Y
    Nihon Rinsho; 1974 Mar; 32(3):446-8. PubMed ID: 4859022
    [No Abstract]   [Full Text] [Related]  

  • 19. Water, electrolytes and protein content of muscle obtained by needle biopsy in uremic children.
    Broyer M; Delaporte C; Maziere B
    Biomedicine; 1974 Jun; 21(6):278-85. PubMed ID: 4441590
    [No Abstract]   [Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.